0001682338-23-000001.txt : 20230105 0001682338-23-000001.hdr.sgml : 20230105 20230105132735 ACCESSION NUMBER: 0001682338-23-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230105 DATE AS OF CHANGE: 20230105 EFFECTIVENESS DATE: 20230105 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Grid Therapeutics LLC CENTRAL INDEX KEY: 0001682338 IRS NUMBER: 813371488 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-469789 FILM NUMBER: 23510484 BUSINESS ADDRESS: STREET 1: THE IMPERIAL BUILDING, 215 MORRIS ST STREET 2: SUITE 300 CITY: DURHAM STATE: NC ZIP: 27701 BUSINESS PHONE: 919987-7190 MAIL ADDRESS: STREET 1: THE IMPERIAL BUILDING, 215 MORRIS ST STREET 2: SUITE 300 CITY: DURHAM STATE: NC ZIP: 27701 FORMER COMPANY: FORMER CONFORMED NAME: Cue Biologics, LLC DATE OF NAME CHANGE: 20160815 D 1 primary_doc.xml X0708 D LIVE 0001682338 Grid Therapeutics LLC THE IMPERIAL BUILDING, 215 MORRIS ST SUITE 300 DURHAM NC NORTH CAROLINA 27701 919-987-7190 DELAWARE Cue Biologics, LLC Limited Liability Company true Edward F. Patz, Jr. The Imperial Building, 215 Morris St Suite 300 Durham NC NORTH CAROLINA 27701 Executive Officer Director Promoter Scott Lyman The Imperial Building, 215 Morris St Suite 300 Durham NC NORTH CAROLINA 27701 Executive Officer Paolo Paoletti The Imperial Building, 215 Morris St Suite 300 Durham NC NORTH CAROLINA 27701 Director Kevin Schulman The Imperial Building, 215 Morris St Suite 300 Durham NC NORTH CAROLINA 27701 Director Richard Parker The Imperial Building, 215 Morris St Suite 300 Durham NC NORTH CAROLINA 27701 Director Thomas Patz The Imperial Building, 215 Morris St Suite 300 Durham NC NORTH CAROLINA 27701 Executive Officer Director Biotechnology Decline to Disclose 06b false 2022-11-19 false true true true false 0 1740000 1740000 0 false 11 0 0 0 true Proceeds will be used for working capital, which may include normal compensation to executive officers. false Grid Therapeutics LLC Edward F. Patz, Jr. Edward F. Patz, Jr. CEO 2023-01-05